Tuesday, 3 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Regulatory Approval

Go Digit General Insurance Regulatory Approval

Go Digit General Insurance received 'no adverse observation' letters from BSE and NSE for its proposed merger with Go Digit Infoworks Services. This regulatory clearance allows the company to proceed with filing the scheme before the NCLT. The observation letters remain valid for six months from April 22, 2026.

Source

BSE filing, NSE: GODIGIT. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Go Digit General Insurance Ltd: key numbers

Share price
₹252.90
Market cap
₹23,324 Cr
Revenue (annual)
₹10,005 Cr
Net profit (annual)
₹544.4 Cr
P/E (TTM)
45.2×Sector 19.1×
Promoter holding
72.96%-0.04% QoQ
FII holding
6.58%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Go Digit General Insurance Ltd

All →

Other regulatory approval announcements

All →
15:23 IST BSE
Regulatory ApprovalJohn Cockerill India Ltd COCKERILL

John Cockerill India Regulatory Approval

John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.

11:28 IST NSE
Regulatory ApprovalGland Pharma Ltd GLAND

Gland Pharma Regulatory Approval

Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.

18:29 IST BSE
Regulatory ApprovalCity Union Bank Ltd CUB

City Union Bank Regulatory Approval

City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.

Execution
Three years from the date of taking charge
18:04 IST BSE
Regulatory ApprovalLupin Ltd LUPIN

Lupin Regulatory Approval

Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.

19:01 IST NSE
Regulatory ApprovalSom Distilleries & Breweries Ltd SDBL

Som Distilleries & Breweries Regulatory Approval

Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.

12:15 IST NSE
Regulatory ApprovalAGI Infra Ltd AGIIL

AGI Infra Regulatory Approval

Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.

Execution
Valid up to March 30, 2031